Chauche Thierry 4
4 · Sagimet Biosciences Inc. · Filed May 8, 2024
Insider Transaction Report
Form 4
Chauche Thierry
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-05-06+587,181→ 587,181 totalExercise: $4.28Exp: 2034-05-05→ Series A Common Stock (587,181 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on May 6, 2025, with the remainder vesting over thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.